Developing a novel, safe drug to prevent heart attacks, strokes, and liver transplants from NASH
157+ Investors // 1New
$100 Min. Investment
@John R Hume
@Manosh k Sinha
✔CEO designed trials for Vascepa®, which reduces heart attack and stroke risk for high triglycerides.
✔Awarded $700k from Dutch government to perform more studies on our drug Corvida™’s potential.
✔Results of Corvida™’s affect on genes associated with atherosclerosis due in 2022.
✔Funds raised will lead to PreIND meetings with the FDA to ensure acceptability of human trials.
✔Corvida™’s components are designated GRAS (Generally Regarded as Safe) by the FDA.
✔Corvida™ is protected by patents in the US and Japan and are owned by the company.
✔This is an opportunity for you to impact global health and potentially realise significant financial gains.
- Category : Domestic, Personal & IT
- Service Type : Home Services